Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis

NCT06231758 is registered in ClinicalTrials.gov with Mostafa Bahaa as lead sponsor.

NCT NCT06231758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06231758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis
Lead sponsor
Mostafa Bahaa
Phase
Phase 3
Overall status
Recruiting
Start date
January 30, 2024
Completion date
November 20, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteo arthritis knee